Serum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Pathogenic Role of Interlukin-23(IL-23) in Rheumatoid Arthritis Patients; its Relation to Disease Activity

Molecular expression and single nucleotide polymorphisms of the IL17A gene among etanercept-treated rheumatoid arthritis patients

Role of interleukin-17 and interleukin 23R gene polymorphism and serum interleukin 17A in rheumatoid arthritis

The Role of Soluble Subtype of the Receptor for Advanced Glycation End Product (sRAGE) in Rheumatoid Arthrirtis Disease Activity and Treatment Follow-up

Association of NF-κB1/IKKε Gene Expression with Disease Activity Indices in Patients with Early Rheumatoid Arthritis

Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity

Association between Interleukin-21 Serum Level and IL-21 Genetic Polymorphism with the Cardiovascular Morbidity Risk in Rheumatoid Arthritis and Systemic Lupus Erythematosus Pati

Sclerostin level in rheumatoid arthritis patients and its relationship to disease severity and bone mineral density